Zacks Research Weighs in on Editas Medicine FY2028 Earnings



Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) – Analysts at Zacks Research issued their FY2028 earnings estimates for Editas Medicine in a note issued to investors on Monday, March 23rd. Zacks Research analyst Team expects that the company will post earnings of ($1.34) per share for the year. Th



Source link

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *